Filana Therapeutics Inc (FLNA) Stock Price, Quote & News

Company Profile

Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer's disease; and investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer's disease from a small sample of blood. The company was formerly known as Cassava Sciences, Inc. and changed its na...

Industry: Biotechnology

Sector: Healthcare

Phone: 512 501 2444

Website: www.filanatx.com

Address:

6801 N. Capital of Texas Highway, Building 1, Austin, United States

Shawshank_book_keeper Aug. 23 at 9:33 PM

$FLNA RECYCLED GARBAGE!!!!

0 · Reply

Shawshank_book_keeper Aug. 23 at 4:39 PM

$FLNA pain therapeutic… cassava sciences… filana therapeutics….. (_____)

0 · Reply

PeterRaslow Aug. 20 at 6:53 PM

$FLNA when will we get the next az trial with a less potent placebo ?

2 · Reply

Dew8 Aug. 20 at 11:34 AM

$FLNA 8.24 average

1 · Reply

fedeperu Aug. 19 at 8:02 PM

$FLNA up today...and tomorrow?

0 · Reply

Albogen Aug. 19 at 7:43 PM

$FLNA hope for turnaround!

0 · Reply

Chrissytina Aug. 19 at 6:41 PM

$FLNA Only a penny flipper would say that.

0 · Reply

Bricktop200 Aug. 19 at 6:33 PM

$FLNA added

1 · Reply

GangsterX Aug. 19 at 6:14 PM

$FLNA Looking good baby

0 · Reply

Shawshank_book_keeper Aug. 18 at 8:19 AM

$FLNA can filana management call the fda and request another trial??? Semifooolam remoxy PT125 still has promise even tho it cannot cross the blood brain barrier 😂

1 · Reply

Did Filana Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Jul 29, 2026, 8:30 AM EDT - 26 days ago

Filana Therapeutics Earnings release: Q2 2026

Jul 29, 2026, 8:30 AM EDT - 26 days ago

Filana Therapeutics Quarterly report: Q2 2026

Jul 29, 2026, 8:00 AM EDT - 26 days ago

Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update

Jul 29, 2026, 7:00 AM EDT - 26 days ago

Filana Therapeutics Slides: Corporate presentation

Jun 11, 2026, 9:30 AM EDT - 2 months ago

Filana Therapeutics Transcript: AGM 2026

2026-05-26T13:58:44.000Z - 3 months ago

Filana Therapeutics resumed with Buy at Maxim on rebranding, strategic pivot

2026-05-26T12:40:15.000Z - 3 months ago

Filana Therapeutics resumed with a Buy at Maxim

May 7, 2026, 8:00 AM EDT - 3 months ago

Filana Therapeutics Reports Q1 2026 Financial Results and Business Update

May 7, 2026, 8:00 AM EDT - 3 months ago

Filana Therapeutics Earnings release: Q1 2026

May 7, 2026, 8:00 AM EDT - 3 months ago

Filana Therapeutics Quarterly report: Q1 2026

May 7, 2026, 7:00 AM EDT - 3 months ago

Filana Therapeutics Slides: Corporate presentation

May 5, 2026, 8:00 AM EDT - 3 months ago

Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII

Apr 28, 2026, 8:00 AM EDT - 4 months ago

Filana Therapeutics Proxy statement: Proxy filing

2026-04-15T12:20:15.000Z - 4 months ago

Filana Therapeutics publishes simufilam preclinical data

2026-03-19T19:25:18.000Z - 5 months ago

Filana Therapeutics management to meet with Maxim

2026-03-12T12:13:27.000Z - 5 months ago

Filana Therapeutics reports Q4 EPS (26c) vs. (57c) last year

2026-03-12T12:12:53.000Z - 5 months ago

Filana Therapeutics sees 1H26 net cash use in operations $14M-$17M

Mar 12, 2026, 8:00 AM EDT - 5 months ago

Filana Therapeutics Annual report: Q4 2025

Mar 12, 2026, 8:00 AM EDT - 5 months ago

Filana Therapeutics Earnings release: Q4 2025

Mar 10, 2026, 7:00 AM EDT - 5 months ago

Filana Therapeutics Slides: Investor presentation

Feb 19, 2026, 8:52 AM EST - 6 months ago

Cassava Sciences says US DOJ has closed investigation into company

Dec 24, 2025, 11:51 AM EST - 8 months ago

HALPER SADEH LLC ENCOURAGES CASSAVA SCIENCES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Nov 13, 2025, 7:00 AM EST - 10 months ago

Filana Therapeutics Registration statement: Registration Filing

Nov 12, 2025, 8:00 AM EST - 10 months ago

Filana Therapeutics Quarterly report: Q3 2025

Nov 12, 2025, 8:00 AM EST - 10 months ago

Filana Therapeutics Earnings release: Q3 2025

Oct 22, 2025, 4:05 PM EDT - 10 months ago

Halper Sadeh LLC Encourages Cassava Sciences, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Oct 22, 2025, 8:00 AM EDT - 10 months ago

Cassava Sciences Appoints Dawn C. Bir to the Board of Directors

Sep 8, 2025, 5:00 PM EDT - 1 year ago

Filana Therapeutics Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Aug 14, 2025, 8:00 AM EDT - 1 year ago

Filana Therapeutics Quarterly report: Q2 2025

Aug 14, 2025, 8:00 AM EDT - 1 year ago

Filana Therapeutics Earnings release: Q2 2025

Aug 14, 2025, 7:30 AM EDT - 1 year ago

Cassava Reports Q2 2025 Financials Results and Provides Business Update

Aug 7, 2025, 7:30 AM EDT - 1 year ago

Cassava Sciences Appoints Dr. Joseph Hulihan as Chief Medical Officer

Aug 4, 2025, 7:30 AM EDT - 1 year ago

Cassava Sciences Reports Positive Preclinical Study Evaluating Simufilam for TSC-Related Epilepsy

Jun 30, 2025, 7:00 AM EDT - 1 year ago

Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting

May 8, 2025, 7:00 AM EDT - 1 year ago

Filana Therapeutics Quarterly report: Q1 2025

May 8, 2025, 7:00 AM EDT - 1 year ago

Filana Therapeutics Earnings release: Q1 2025

May 1, 2025, 7:30 AM EDT - 1 year ago

Cassava Appoints Angélique Bordey, PhD, to Enhance Preclinical Program in TSC

Apr 21, 2025, 4:30 PM EDT - 1 year ago

Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development

Apr 14, 2025, 8:00 AM EDT - 1 year ago

Filana Therapeutics Proxy statement: Proxy Filing

Apr 3, 2025, 8:00 AM EDT - 1 year ago

Filana Therapeutics Proxy statement: Proxy Filing

Mar 26, 2025, 3:49 PM EDT - 1 year ago

Cassava Sciences must face malicious prosecution lawsuit over Alzheimer's drug

Mar 25, 2025, 8:05 AM EDT - 1 year ago

Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data

Mar 3, 2025, 7:30 AM EST - 1 year ago

Cassava Sciences Reports 2024 Financial Results and Provides Business Update

Mar 3, 2025, 7:30 AM EST - 1 year ago

Filana Therapeutics Annual report: Q4 2024

Mar 3, 2025, 7:30 AM EST - 1 year ago

Filana Therapeutics Earnings release: Q4 2024

Jan 7, 2025, 4:30 PM EST - 1 year ago

Cassava Sciences Provides a Business Update

Shawshank_book_keeper Aug. 23 at 9:33 PM

$FLNA RECYCLED GARBAGE!!!!

0 · Reply

Shawshank_book_keeper Aug. 23 at 4:39 PM

$FLNA pain therapeutic… cassava sciences… filana therapeutics….. (_____)

0 · Reply

PeterRaslow Aug. 20 at 6:53 PM

$FLNA when will we get the next az trial with a less potent placebo ?

2 · Reply

Dew8 Aug. 20 at 11:34 AM

$FLNA 8.24 average

1 · Reply

fedeperu Aug. 19 at 8:02 PM

$FLNA up today...and tomorrow?

0 · Reply

Albogen Aug. 19 at 7:43 PM

$FLNA hope for turnaround!

0 · Reply

Chrissytina Aug. 19 at 6:41 PM

$FLNA Only a penny flipper would say that.

0 · Reply

Bricktop200 Aug. 19 at 6:33 PM

$FLNA added

1 · Reply

GangsterX Aug. 19 at 6:14 PM

$FLNA Looking good baby

0 · Reply

Shawshank_book_keeper Aug. 18 at 8:19 AM

$FLNA can filana management call the fda and request another trial??? Semifooolam remoxy PT125 still has promise even tho it cannot cross the blood brain barrier 😂

1 · Reply

Shawshank_book_keeper Aug. 18 at 8:15 AM

$FLNA this company needs new management

0 · Reply

To_De_Moon Aug. 17 at 9:09 PM

$FLNA 🔥

1 · Reply

MOOSEN Aug. 16 at 1:49 AM

$AVXL $CVM $FLNA $NWBO $SLS THE SAME PATTERN? HAVE YOU EVEN VIEWED THE 5Y CHARTS OF THE FOUR TICKERS YOU LISTED ALONGSIDE OF $SLS ??? PLEASE DO RUN AN ANALYSIS OF YOUR PATTERN THESIS IN-CORRELATION FOR US…

3 · Reply

PeterRaslow Aug. 13 at 8:46 PM

$FLNA is simufilam curing az or not ?

3 · Reply

focafoca99 Aug. 12 at 6:30 PM

$FLNA explains a legal rights notice as a shareholder-rights investigation by Halper Sadeh LLC. https://www.rapidticker.com/news/flna-did-filana-therapeutics-inc-insiders-559576

0 · Reply

jackcoltrain Aug. 11 at 6:24 PM

$SLS This garbage follows the same pattern as $CVM, $FLNA , $AVXL , $NWBO , and all the other biotech cult garbage we've seen in the past: 1. cult-like following by idiots leading to huge stock price increase 2. ZERO biotech investment firms in the stock 3. history of paying penny stock promoters for coverage As Floyd Mayweather likes to say: easy money!

10 · Reply

BioGLovesMe Aug. 10 at 8:01 PM

$FLNA When delisting notice?

0 · Reply

RajeshKPatel Aug. 8 at 6:28 PM

$FLNA , They fucking changed the name so loot can continue! Nothing changed other than the name !!

2 · Reply

Shawshank_book_keeper Aug. 8 at 2:15 AM

$FLNA sava vs flna

1 · Reply

Shawshank_book_keeper Aug. 7 at 4:52 PM

$FLNA great earnings report

1 · Reply

StocktwitsNews Aug. 7 at 2:50 PM

FLNA Q2 2026 Earnings Summary $FLNA https://stocktwits.com/news/earnings/earnings/flna-q2-2026-earnings-summary/cZofISmRJ95

0 · Reply

To_De_Moon Aug. 7 at 2:33 PM

$FLNA up

0 · Reply

Market Cap	46.42M
Revenue (ttm)	0.00
Net Income (ttm)	-90.97M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	83,368
Avg Vol	342,504
Day's Range	N/A - N/A
Shares Out	48.31M
Stochastic %K	60%
Beta	-0.70
Analysts	Strong Sell
Price Target	$6.50